This clinical trial is focused on studying the effects of a treatment for individuals experiencing symptoms of anxiety disorders and Post-Traumatic Stress Disorder (PTSD). The treatment being tested is a substance called Cannabidiol (CBD), which is a chemical compound found in cannabis plants. In this study, CBD is administered in the form of capsules. The purpose of the study is to explore how a two-week course of CBD might help reduce anxiety symptoms before starting therapy for anxiety or PTSD.
The study involves participants who are Dutch uniformed personnel, such as police officers, firefighters, ambulance paramedics, military personnel, or veterans. Participants will take CBD capsules daily for two weeks. During this period, researchers will monitor changes in anxiety levels using a tool called Beck’s anxiety index. Additionally, the study will assess how CBD affects fear responses, stress regulation, and sleep quality. These assessments will involve questionnaires, physiological measurements, and a sleep watch to gather comprehensive data on the effects of CBD.
By examining these factors, the study aims to provide insights into whether CBD can be beneficial in managing anxiety symptoms and improving overall well-being before starting traditional therapy for anxiety or PTSD. The findings could potentially lead to new approaches in preparing individuals for therapy, enhancing their treatment outcomes.



The Netherlands